{"id":49065,"date":"2022-10-03T08:01:51","date_gmt":"2022-10-03T06:01:51","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\/"},"modified":"2022-10-03T08:01:51","modified_gmt":"2022-10-03T06:01:51","slug":"autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\/","title":{"rendered":"Autologous immune-cell therapy, practiced in Japan, now helping Vinmec Hospital, treat cancer patients in Hanoi, Vietnam, after technology transfer by GN Corporation"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Hyperthermia system made in Japan, benefitting cancer patients, attracts the interest of overseas cancer hospitals.<\/i>\n<\/p>\n<p>TOKYO&#8211;(BUSINESS WIRE)&#8211;Treatment of cancer using one\u2019s own immune cells, natural killer (NK) cells and T-cells, called <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.immunotreatment.org&amp;esheet=52934281&amp;newsitemid=20221002005087&amp;lan=en-US&amp;anchor=autologous+immune+enhancement+cell+therapy&amp;index=1&amp;md5=0290672775a207315522dfb5cc4b4f05\" rel=\"nofollow noopener\" shape=\"rect\">autologous immune enhancement cell therapy<\/a> (AIET) administered along with conventional chemotherapy, radiotherapy and surgery, practiced in Japan for long is now offered in <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vinmec.com%2Fen%2F&amp;esheet=52934281&amp;newsitemid=20221002005087&amp;lan=en-US&amp;anchor=Vinmec+hospital%2C+Hanoi&amp;index=2&amp;md5=14a0308fa3e4cb3ff73748920958bf5d\" rel=\"nofollow noopener\" shape=\"rect\">Vinmec hospital, Hanoi<\/a>, Vietnam, following <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F31261712%2F&amp;esheet=52934281&amp;newsitemid=20221002005087&amp;lan=en-US&amp;anchor=technology+transfer&amp;index=3&amp;md5=c80d1b0df20de7609a7b6673093fb1e8\" rel=\"nofollow noopener\" shape=\"rect\">technology transfer<\/a> by <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fgncorporation.com%2Fen%2Fcancer-immunotherapy-en%2F&amp;esheet=52934281&amp;newsitemid=20221002005087&amp;lan=en-US&amp;anchor=GN+Corporation&amp;index=4&amp;md5=c87508260c88b89c55452f01b79c1889\" rel=\"nofollow noopener\" shape=\"rect\">GN Corporation<\/a>. Cancer patients from neighboring countries are now visiting Vinmec hospital for this treatment. Autologous immune-cell therapy, regulated by the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.pmda.go.jp%2Ffiles%2F000219466.pdf&amp;esheet=52934281&amp;newsitemid=20221002005087&amp;lan=en-US&amp;anchor=regenerative+medicine+law+in+Japan&amp;index=5&amp;md5=1d0e70db05e86e472098e23e3b78cba6\" rel=\"nofollow noopener\" shape=\"rect\">regenerative medicine law in Japan<\/a>, uses lab-expanded autologous immune cells, without animal proteins or genetic manipulation.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221002005087\/en\/1589233\/5\/GNC_49_PR_Vinmec_TT_BW_Picture.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221002005087\/en\/1589233\/21\/GNC_49_PR_Vinmec_TT_BW_Picture.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20221002005087\/en\/1589232\/5\/GNC_Logo_49PR_BW_03oct22.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221002005087\/en\/1589232\/21\/GNC_Logo_49PR_BW_03oct22.jpg\"><\/a><\/p>\n<p>\n<b>Benefits of AIET &amp; hyperthermia: <\/b>While<b> <\/b>increase in survival rate in cancer patients is reported by adding <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3908307%2F&amp;esheet=52934281&amp;newsitemid=20221002005087&amp;lan=en-US&amp;anchor=immune-cell+therapy&amp;index=6&amp;md5=00cd68d41c821f214c80d813a629ffc1\" rel=\"nofollow noopener\" shape=\"rect\">immune-cell therapy<\/a> to conventional treatment regimen, the Hyperthermia system developed in Japan further <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F29066122%2F&amp;esheet=52934281&amp;newsitemid=20221002005087&amp;lan=en-US&amp;anchor=improves+outcome&amp;index=7&amp;md5=81464ad6242b576562e12301abf4bdb9\" rel=\"nofollow noopener\" shape=\"rect\">improves outcome<\/a> of cancer treatment as it targets the cancer cells, vulnerable to damage at a higher temperature of 42 Deg Celsius.<b> <\/b>To propagate these add-on cancer treatments to overseas hospitals, GNC Japan is collaborating with Yamamoto Vinita, manufacturers of <b>Thermotron<\/b>, the first hyperthermia equipment to treat malignant tumors, approved in Japan, installed in more than 300 hospitals in six countries, till date. The <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.hytemforcancer.com%2F&amp;esheet=52934281&amp;newsitemid=20221002005087&amp;lan=en-US&amp;anchor=latest+Thermotron-RF8-EX&amp;index=8&amp;md5=2703321aca55be53e233821dbea29ab9\" rel=\"nofollow noopener\" shape=\"rect\">latest Thermotron-RF8-EX<\/a> version is a stand-alone system with Eight MHZ radiofrequency, uses electrodes of different sizes in combination to treat superficial and deep-seated solid tumors of the entire body except eye and brain.\n<\/p>\n<p>\n<b>Thermotron RF8-EX Salient features:<\/b>\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nEnhances the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdoi.org%2F10.1016%2Fj.addr.2020.07.007&amp;esheet=52934281&amp;newsitemid=20221002005087&amp;lan=en-US&amp;anchor=beneficial+effects&amp;index=9&amp;md5=c1e9ab63589302e8485f47f8d20b40ec\" rel=\"nofollow noopener\" shape=\"rect\">beneficial effects<\/a> of <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fdoi.org%2F10.1016%2Fj.addr.2020.01.003&amp;esheet=52934281&amp;newsitemid=20221002005087&amp;lan=en-US&amp;anchor=chemotherapy+and+radiotherapy&amp;index=10&amp;md5=c770e732ffba9082faf68abe3e6e4a25\" rel=\"nofollow noopener\" shape=\"rect\">chemotherapy and radiotherapy<\/a>\n<\/li>\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F16201106%2F&amp;esheet=52934281&amp;newsitemid=20221002005087&amp;lan=en-US&amp;anchor=Improves+immunity&amp;index=11&amp;md5=14266e20912c8f30f2a68b6e63f89657\" rel=\"nofollow noopener\" shape=\"rect\">Improves immunity<\/a> and also the quality of life of cancer patients\n<\/li>\n<li>\nNo radiation and therefore no need for any shielding\n<\/li>\n<li>\nEasy raise of temperature of the target lesion region\n<\/li>\n<li>\nSafety track record since 1980 in more the 300 cancer hospitals\n<\/li>\n<\/ul>\n<p>\nHospitals in Japan offering these cancer therapies receive patients from abroad for treatment. Recently overseas cancer hospitals have started showing interest in adding these two therapies to their existing systems for cancer treatment in clinical oncology services.\n<\/p>\n<p>\nAccomplishments of GN Corporation, in adding value to Japanese technologies by inter-disciplinary interaction, developing novel healthcare solutions and global propagation were featured by Govt of Japan in the <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DDGrcWyxPrrc&amp;esheet=52934281&amp;newsitemid=20221002005087&amp;lan=en-US&amp;anchor=official+YouTube+channel+of+the+prime+minister%26%238217%3Bs+office+of+Japan&amp;index=12&amp;md5=50a8844c6989cd350fc7a39df44641de\" rel=\"nofollow noopener\" shape=\"rect\">official YouTube channel of the <b>prime minister\u2019s office of Japan<\/b><\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.japan.go.jp%2Feconomy%2Finvestment%2Findex.html&amp;esheet=52934281&amp;newsitemid=20221002005087&amp;lan=en-US&amp;anchor=JETRO+Invest+in+Japan+portal&amp;index=13&amp;md5=a5d630794a7b5e7d01fe8f1d1c243cc4\" rel=\"nofollow noopener\" shape=\"rect\">JETRO<b> Invest in Japan<\/b> portal<\/a> and a feature story sponsored by <b>Govt of Japan in <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fsponsored.bloomberg.com%2Farticle%2Fjco%2Fjapan-where-high-tech-meets-high-value-foreign-direct-investment&amp;esheet=52934281&amp;newsitemid=20221002005087&amp;lan=en-US&amp;anchor=Bloomberg&amp;index=14&amp;md5=cebd4c7b9386ba0c6ce66d3832d10e3b\" rel=\"nofollow noopener\" shape=\"rect\">Bloomberg<\/a><\/b>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nSamuel JK Abraham<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#116;o&#x3a;&#x69;&#110;&#x66;&#x6f;&#64;g&#x6e;&#99;o&#x72;&#x70;&#111;&#x72;&#x61;&#116;i&#x6f;&#110;&#46;&#x63;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#105;n&#x66;o&#x40;g&#x6e;&#99;&#x6f;&#114;&#x70;&#111;r&#x61;t&#x69;o&#x6e;&#46;&#x63;&#111;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Hyperthermia system made in Japan, benefitting cancer patients, attracts the interest of overseas cancer hospitals. TOKYO&#8211;(BUSINESS WIRE)&#8211;Treatment of cancer using one\u2019s own immune cells, natural killer (NK) cells and T-cells, called autologous immune enhancement cell therapy (AIET) administered along with conventional chemotherapy, radiotherapy and surgery, practiced in Japan for long is now offered in Vinmec &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49065","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Autologous immune-cell therapy, practiced in Japan, now helping Vinmec Hospital, treat cancer patients in Hanoi, Vietnam, after technology transfer by GN Corporation - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Autologous immune-cell therapy, practiced in Japan, now helping Vinmec Hospital, treat cancer patients in Hanoi, Vietnam, after technology transfer by GN Corporation - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Hyperthermia system made in Japan, benefitting cancer patients, attracts the interest of overseas cancer hospitals. TOKYO&#8211;(BUSINESS WIRE)&#8211;Treatment of cancer using one\u2019s own immune cells, natural killer (NK) cells and T-cells, called autologous immune enhancement cell therapy (AIET) administered along with conventional chemotherapy, radiotherapy and surgery, practiced in Japan for long is now offered in Vinmec ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-03T06:01:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221002005087\/en\/1589233\/21\/GNC_49_PR_Vinmec_TT_BW_Picture.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Autologous immune-cell therapy, practiced in Japan, now helping Vinmec Hospital, treat cancer patients in Hanoi, Vietnam, after technology transfer by GN Corporation\",\"datePublished\":\"2022-10-03T06:01:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\\\/\"},\"wordCount\":400,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221002005087\\\/en\\\/1589233\\\/21\\\/GNC_49_PR_Vinmec_TT_BW_Picture.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\\\/\",\"name\":\"Autologous immune-cell therapy, practiced in Japan, now helping Vinmec Hospital, treat cancer patients in Hanoi, Vietnam, after technology transfer by GN Corporation - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221002005087\\\/en\\\/1589233\\\/21\\\/GNC_49_PR_Vinmec_TT_BW_Picture.jpg\",\"datePublished\":\"2022-10-03T06:01:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221002005087\\\/en\\\/1589233\\\/21\\\/GNC_49_PR_Vinmec_TT_BW_Picture.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221002005087\\\/en\\\/1589233\\\/21\\\/GNC_49_PR_Vinmec_TT_BW_Picture.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Autologous immune-cell therapy, practiced in Japan, now helping Vinmec Hospital, treat cancer patients in Hanoi, Vietnam, after technology transfer by GN Corporation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Autologous immune-cell therapy, practiced in Japan, now helping Vinmec Hospital, treat cancer patients in Hanoi, Vietnam, after technology transfer by GN Corporation - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\/","og_locale":"en_US","og_type":"article","og_title":"Autologous immune-cell therapy, practiced in Japan, now helping Vinmec Hospital, treat cancer patients in Hanoi, Vietnam, after technology transfer by GN Corporation - Pharma Trend","og_description":"Hyperthermia system made in Japan, benefitting cancer patients, attracts the interest of overseas cancer hospitals. TOKYO&#8211;(BUSINESS WIRE)&#8211;Treatment of cancer using one\u2019s own immune cells, natural killer (NK) cells and T-cells, called autologous immune enhancement cell therapy (AIET) administered along with conventional chemotherapy, radiotherapy and surgery, practiced in Japan for long is now offered in Vinmec ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-03T06:01:51+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221002005087\/en\/1589233\/21\/GNC_49_PR_Vinmec_TT_BW_Picture.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Autologous immune-cell therapy, practiced in Japan, now helping Vinmec Hospital, treat cancer patients in Hanoi, Vietnam, after technology transfer by GN Corporation","datePublished":"2022-10-03T06:01:51+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\/"},"wordCount":400,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221002005087\/en\/1589233\/21\/GNC_49_PR_Vinmec_TT_BW_Picture.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\/","url":"https:\/\/pharma-trend.com\/en\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\/","name":"Autologous immune-cell therapy, practiced in Japan, now helping Vinmec Hospital, treat cancer patients in Hanoi, Vietnam, after technology transfer by GN Corporation - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221002005087\/en\/1589233\/21\/GNC_49_PR_Vinmec_TT_BW_Picture.jpg","datePublished":"2022-10-03T06:01:51+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221002005087\/en\/1589233\/21\/GNC_49_PR_Vinmec_TT_BW_Picture.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221002005087\/en\/1589233\/21\/GNC_49_PR_Vinmec_TT_BW_Picture.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/autologous-immune-cell-therapy-practiced-in-japan-now-helping-vinmec-hospital-treat-cancer-patients-in-hanoi-vietnam-after-technology-transfer-by-gn-corporation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Autologous immune-cell therapy, practiced in Japan, now helping Vinmec Hospital, treat cancer patients in Hanoi, Vietnam, after technology transfer by GN Corporation"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49065","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49065"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49065\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49065"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49065"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49065"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}